Hims vs Thryve
Hims and Thryve sell different medications; this is what separates them.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Hims
Best for: knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC
Visit Hims →
If you are choosing between Hims and Thryve, price alone will not settle it. Hims leads our six-part score, 6.8 to 5.2. One of the two has an FDA warning letter on record, covered below.
Hims vs Thryve price
Hims publishes $199 a month. Thryve does not post a GLP-1 price we can quote, so you would only learn its cost after an intake.
Medications and formats
Hims lists semaglutide and tirzepatide; Thryve does not name its drug.
On format, Hims prices compounded injections and brand-name pens, while Thryve posts no priced format.
If you want the FDA-approved brand rather than a compounded version, Hims is the only one of the two with a brand-name price.
Where each one treats patients
Hims lists 50 states, and Thryve does not publish where it ships.
Pricing
Hims
Brand Zepbound from $299/mo medication-only; requires Hims Weight Loss Membership ($149/mo)
Thryve
Pricing not publicly listed.
What each price covers
Hims' price also covers the medication itself, which Thryve does not claim.
Hims is silent on shipping and lab work.
Thryve does not say what its price includes.
That matters most for the drug: unless Thryve confirms otherwise, budget for medication on top of its listed price.
Hims
Covered by the monthly price
Medication
In the price
Clinician visits
Charged on top
Shipping
Not stated
Lab work
Not stated
Coaching
Charged on top
Thryve
Inclusions not disclosed.
Where each one scores higher
Overall, Hims scores 6.8 and Thryve 5.2 out of 10.
Hims is stronger on effectiveness (10.0 vs 5.0), trust & safety (7.0 vs 6.5) and accessibility (10.0 vs 5.0).
Thryve is stronger on support (5.0 vs 3.0).
Value and user experience are within half a point.
Hims
6.8/10
Thryve
5.2/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
The FDA sent Hims a warning letter dated September 9, 2025 (letter 716567), and it is still open.
Thryve has no FDA warning letter on record with us.
Features & Coverage
| Feature | Hims | Thryve |
|---|---|---|
| Starting Price | $199/mo | Not published |
| Features | 2 features | ✓3 features |
| States Available | 50 | Not disclosed |
| Compounded | ✓ Yes | — |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | 1 letter | ✓None |
About Hims
Hims is a major men's telehealth brand. Its weight loss offering is compounded semaglutide on a 6-month plan.
Read our full Hims review →About Thryve
$99 a month is the advertised entry into what is called a GLP-1 peptide program. Neither tirzepatide nor semaglutide is named, nor is anything else; the only description offered is "a peptide currently under clinical research." Neither the Privacy Policy page nor the Terms of Service page works at the time of this review, and clicking Get Started leads to no intake or signup flow at all.
Read our full Thryve review →Pros & Cons
Hims
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication
- Serves all 50 states
- Names 4 pharmacies that fill its prescriptions, which most sellers do not
Watch-outs
- Not included in the monthly price: clinician visits, coaching
- The FDA has issued Hims a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
- Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
Thryve
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- We found no FDA warning letters issued to Thryve
Watch-outs
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
Our Verdict
Hims wins this one, 6.8 to 5.2, above all for knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC.
Choose Hims if…
You want knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC and an opening price near $199 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Strut Health
Semaglutide at $99/month, 48% below the typical price
From $99/mo
Get started →Enhance MD
Knowing which pharmacy fills the vial: it names Tru Meds Rx
From $169/mo
Get started →DudeMeds
Compounded semaglutide at $175/month
From $175/mo
Get started →Hims vs Thryve: FAQ
Close alternatives to Hims and Thryve
- Hims vs Hers
- Hims vs Care Bare Rx
- Hims vs Concierge MD LA
- Hims vs Corsica Health
- Thryve vs Embody
- Thryve vs TrimRx
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.